Evidence map›Paper›PMID 34600247›Full record

ArticleDrug and alcohol dependence2021

Detecting change in psychiatric functioning in clinical trials for cocaine use disorder: sensitivity of the Addiction Severity Index and Brief Symptom Inventory.

Brian D Kiluk, Corey R Roos, Mihaela Aslan, Ralitza Gueorguieva, Charla Nich, Theresa A Babuscio, Kathleen M Carroll

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Quality-of-life improvements associated with reductions in cocaine-positive urine drug screens.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2026
    Trial
  2. Trial
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Brian D KilukYale School of Medicine, United States. Electronic address: brian.kiluk@yale.edu.
Corey R RoosYale School of Medicine, United States.
Mihaela AslanYale School of Medicine, United States.
Ralitza GueorguievaYale School of Medicine, United States.
Charla NichYale School of Medicine, United States.
Theresa A BabuscioYale School of Medicine, United States.
Kathleen M CarrollYale School of Medicine, United States.
Yale University · US

Funding

Development of the Stimulant Use Disorder Severity ScaleU01DA051639 · NIDA · YALE UNIVERSITY · PI KILUK, BRIAN D. · 2020 to 2023
$1.8M
Identification of a Meaningful Cocaine Use Outcome MeasureR33DA041661 · NIDA · YALE UNIVERSITY · PI KILUK, BRIAN D. · 2018 to 2020
$1.1M
Integrating Cognitive Neuroscience Toward Understanding of Mechanisms of CBT for Alcohol Use DisordersK02AA027300 · NIAAA · YALE UNIVERSITY · PI KILUK, BRIAN D. · 2019 to 2023
$719k
NIAAA NIH HHS K02 AA027300NIDA NIH HHS R33 DA041661NIDA NIH HHS U01 DA051639
6 · The paper itself

Abstract

backgroundAssessment instruments commonly used in clinical trials to measure functional outcomes in substance users may lack sensitivity to detect change during treatment, potentially limiting findings regarding benefits of reduced drug use. This study evaluated the sensitivity of the Addiction Severity Index (ASI) to detect change in psychiatric functioning among cocaine users.

methodsData were pooled across five clinical trials for cocaine use disorder (N = 492) that included a 12-week treatment period and 6-month follow-up. Within-person cohen's d' was used to evaluate effect size of change on the Psychiatric Composite Score of the ASI (ASI-Psych) and Global Severity Index (GSI) of the Brief Symptom Inventory, as well as cocaine use.

resultsEffect sizes were larger for GSI than ASI-Psych from baseline to week 12 (GSI d' = 0.59; ASI-Psych d' = 0.16), and 6-month follow-up (GSI d' = 0.48; ASI-Psych d' = 0.10). For those with non-zero ASI-Psych at baseline (n = 252), medium effect sizes were found over the 12-week period (d' = 0.53) and 6-month follow-up (d' = 0.47). Effect sizes for change in days of cocaine use were most similar to GSI in either sample.

conclusionsThe ASI Psychiatric Composite Score may have limited sensitivity to detect change in psychiatric functioning among clinical trial participants who reduce cocaine use. It may be useful for detecting change amongst those reporting some psychiatric problems at the start of treatment. Future research should consider an instrument's sensitivity to change when assessing the potential functional benefits of reducing cocaine use.

Indexed as

CocaineCocaine-Related DisordersSubstance-Related DisordersHumansCocaineAddiction Severity IndexCocaine use disorderGlobal Severity IndexPsychiatric functioningSensitivity

Identifiers

PMID34600247
PMCPMC8595796
OpenAlexW3200875213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.